Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Genmab
M.D. Anderson Cancer Center
Atavistik Bio, Inc
M.D. Anderson Cancer Center
University of Miami
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Washington University School of Medicine
Sensei Biotherapeutics, Inc.
Jonsson Comprehensive Cancer Center
University of Alabama at Birmingham
Elevation Oncology
Cedars-Sinai Medical Center
Universitair Ziekenhuis Brussel
Genmab
Kineta Inc.
Main Line Health
Imperial College London
Mary Crowley Medical Research Center
Albert Einstein College of Medicine
Instituto do Cancer do Estado de São Paulo
Mayo Clinic
Universidade Federal de Goias
University of Michigan
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Duke University
Memorial Sloan Kettering Cancer Center
Nova Scotia Health Authority
ImmunoFrontier, Inc.
St. Luke's-Roosevelt Hospital Center